Globeflex Capital’s Bio-Techne TECH Stock Holding History

Globeflex Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,016	Closed	-$285K	–	527
2022 Q3	$285K	Buy	4,016 +2,396	+148%	+$207K	0.05%	321
2022 Q2	$140K	Hold	1,620	–	–	0.03%	347
2022 Q1	$175K	Hold	1,620	–	–	0.04%	352
2021 Q4	$210K	Hold	1,620	–	–	0.04%	351
2021 Q3	$196K	Hold	1,620	–	–	0.04%	332
2021 Q2	$182K	Hold	1,620	–	–	0.03%	381
2021 Q1	$155K	Hold	1,620	–	–	0.03%	389
2020 Q4	$129K	Sell	1,620 -156	-9%	-$11.3K	0.03%	404
2020 Q3	$110K	Buy	+1,776	New	+$116K	0.03%	400
2014 Q4	–	Sell	-8,000	Closed	-$187K	–	583
2014 Q3	$187K	Hold	8,000	–	–	0.02%	358
2014 Q2	$185K	Hold	8,000	–	–	0.02%	366
2014 Q1	$170K	Sell	8,000 -800	-9%	-$18K	0.02%	353
2013 Q4	$208K	Buy	+8,800	New	+$191K	0.03%	350

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Globeflex Capital's TECH Position: Q4 2022 in Review

Globeflex Capital sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 4,016 shares — an estimated $285K sold.

Globeflex Capital first reported a position in TECH in Q4 2013 and held it in 13 quarters. The position peaked at $285K in Q3 2022. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

Globeflex Capital reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
Globeflex Capital sold 4,016 Bio-Techne shares in Q4 2022, an estimated $285K.
Globeflex Capital first reported a position in Bio-Techne in Q4 2013 and held it in 13 quarters.
Globeflex Capital's Bio-Techne position peaked at $285K in Q3 2022.
545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Globeflex Capital's 13F filing for Q4 2022, filed 10 Feb 2023.